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We report here the regulation of the biosynthesis and the secretion of C-type natriuretic peptide (CNP) in cultured bovine chromaffin cells. The 
combined treatment with protein kinase A and -C activators induced a 6-fold incl'r, ase of intracellular levels of CNP-(1-103). The biosynthesized 
CNP-(I-103) wa~ co-released with its mature forms, typically CNP-(51-103), upon stimulation by nicotine or depolarizing agents. This confirms 
the neuropeptidic character of this third member of the nalriuretie peptide family, which might act as a neuromodulator or neurotransmitter. 
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1. INTRODUCTION 
Cardiac natriuretic peptides are a family of factors 
isolated from cardiac and brain extracts, sharing com- 
mon regulatory properties of vascular tone, kidney 
function and blood pressure. They include atrial nutria- 
retie factor (ANF), brain natriuretic peptide (BNP) and 
C-type natriuretic peptide (CNP). This third hormone, 
a 22 amino acid peptide, CNP-(82-103), and its elon- 
gated form of 53 residues, CNP-(51-103), first isolated 
from porcine brain [1,2], appears to be exclusively local- 
ized in the central nervous system according to North- 
ern analysis of CNP mRNA distribution, and ina- 
munoreactivity detection in various porcine and rat tis- 
sues [3,4]. Moreover, high immunoreactivity levels are 
not only detected in specific regions of  human brain, 
such as the hypothalamus and the cerebellum, but also 
in the pituitary gland, suggesting its role as a neuromod- 
alator [5]. In fact, CNP appears to bind and activate the 
ANP-B receptors which are found in the brain and pitu- 
itary gland as well as in the adrenal medulla [6]. How- 
ever, the sites and regulation of the biosynthesis for this 
peptide have not yet been documented. In our prelimi- 
nary experiments, we have detected CNP immunoreac- 
tire-like activity within bovine chromaf'fin granules. 
This prompted us to select bovine chromaffin cells as a 
model to document the biosynthesis and secretion of' 
this peptide. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Rat CNP-(82-103) and CNP-(51-103) and anti-rat CNP antiserum 
were obtained from Peninsula Laboratories (Belmont, CA). Carrier- 
free Na'-'~I was from Amersham Corp. (Arlington Heights, IL). Enzy- 
mobeads were purch~ed from Bio-Rad (Richmond, CA). Bovine 
serum albumin, collagenas¢, Dl'qAse, aprotinin, leupeptin, pepstatin 
A, phenylmethylsuifonyl fluoride (PMSF), thiorphan, phorbol ester 
(12-O-tetradeeanoyl phorbol-13-acetate, TPA), forskolin (FKL), 
norepinephriae bitartrate, epinephrine bitartrate, and dihydroxyben- 
zylaminc-HBr were all purchased from Sigma (St. Louis, Me). All 
tissue culture media, sera and antibiotics were obtained from Gibeo 
(Grand Island, NY). All chromatographic solvents were obtained 
from Burdiek and Jackson (Muskegon, MI). 
2.2. Chromaffin cell culture and peptide xtraction 
Chromaffin cells were isolated from bovine adrenal medullae ac- 
cording to Livett's method [4]. Briefly, adrenal glands were peffused 
for 30 rain at 37°C in a retrograde manner with Ca 2.- and Mg:'-free 
Locke's buffer containing 0.25% (w/v) collagenase and 0.025% 
DNAse. The Ca ~+, M82÷-free Locke's buffer consisted of (in raM): 
NaC1145, KCI 5.6, glucose 5.6 and HEPES 10, pH 7.4. The medullary 
tissue was then isolated, finely minced and incubated with fresh col- 
lagenase for another 30 min. Chromaffin cells were then washed twice 
in Lock¢'z solution for 7 rain at 250 × g. Plating was accomplished in
75 ¢m 2 flasks (Miles Scientific, Napierville, IL) at a density o1' 2 × 10 7 
cells in FI2 medium supplemented with 10% (v/v) horse serum, 2% 
fetal bovine serum, 100 U/ml penicillin G sulfate, 100/gg/ml strepto- 
mycin sulfate and 2.5/gg/ml amphotericin B. CNP biosynthesis studies 
were carried out 4S h after plating. Chromaflin ceils were exposed to 
FKL (1 pM), TPA (0.1/zM) or to both agents imultaneously for72 
h. After this treatment, the monolayers were washed twice with 
Locke's buffer and cells were harvested in 2 M acetic acid containing 
20 mM HCl, 0.1 mM EDTA, 0.1 mM PMflF and 0.01 mM l~pstatin 
A. The cell suspensions were then sonicated, centrifuged at30,000 × 8" 
for b0 min and the supernatants were subjected to HPLC analysis. 
CNP secretion . . . .  - tata~e-, were perforr~led 4 days aRer hlltlat"''"t platt,  l, ,g-l"':- 'h, ltAA'"'t" 
cells previously treated with both FKL and TPA. After washing with 
Locke's buffer, monolayers were esposed for 20 mln at 37°C to nice- 
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tlne (10 itM) or KCI (56 mM) in Locke's solution containing 2.2 mM 
CaCl~ and protease inhibitors such as PMSF (1 raM), aprotinin (2 
/tg/ml), leupeptin (5/zg/ml) and pepstatin (5/~g/ml), Secretion media 
from 0 × 107 cells were pooled and acidified to a tinal concentration 
of 1% trifluoroacetic before HPLC analysis. 
2.3. Natriuretic peptMe assay and data analysis 
HPLC analysis of both cell extracts and secretion media was per- 
formed according to the method of Nguyen et al. [8]. Briefly, samples 
were first loaded onto a reverse-phase precolumn (RP-300, 4.6 × 30 
ram) (Brownlee Labs., Santa Clara, CA) at a flow rate of 2 ml/min 
using a mobile phase consisting of 15% acetonitrile (CH.~CN) in 25 
mM triethylamine-format¢ buffer, pH 4. After washing with the same 
buffer, the precolumn was connected online with a reverse-phase ana- 
lytical column (Vydac C,~, 0.46 × 25 era) (Separation group, Hesperia, 
CA) through a switching valve. Mature and precursor forms of CNP 
were then separated with a 40 min linear gradient from 15 to 55% of 
CH~CN in 25 mM triethylamine lbrmate, pH 4, at a flow rate of 1 
ml/min. Fractions of I ml were collected and dried under reduced 
pressure prior to estimation by radioimmtmoassay for CNP. CNP- 
(82-103) was radioiodinated by solid phase using Enzymobeads (Bin- 
Red, Richmond, CA) according to the mamafacturer% directives. The 
radiolabelled peptide was then purified by reverse-phase HPLC on an 
Exsil Cl~ column (0.46 x 15 em) (CSC, Montreal, Qu&) using a linear 
gradient of CH3CN (0.5%/rain) in 0.1% trifluoroacetic a id. The spe- 
cific activity of the monoiodinated peptide was 1,500 Ci/mmol, as 
determined by self-dlsplacement using a specific radioimmunoassay 
for CNP. The radioimmtmoassay conditions for CNP eons;sted of 
standards or reconstituted HPLC fractions in 50 mM phosphate assay 
buffer, pH 7.4 (100/zl), [~:~I]CNP-(82-103) (100 ~tl, 15,000 cpm), anti- 
serum (50/el). The anti-rat CNP antiserum displays full crossreactivity 
between both forms of CNP, namely CNP-(82-103) and CNP- (51- 
103). Standard curves for CNP were constructed from 1 to 105 fmol 
per tube in the assay buffer. The incubation was set for 24 h at 4°C. 
Bound and free fractions of [1"~1]CNP-(82-103) were separated by the 
polyethylene 81ycol method and data were computer analyzed using 
the four parameter logistic equation [9]. Statistical differences between 
treatment groups were evaluated by one way analysis of variance 
followed by Dunnett's test for post hoe multiple comparisons. The 
contrast between the combin~ treatment with FKL and TPA as 
compared to the individual treatments with FKL or TPA was used to 
evaluate the synergistic effect of the combined treatment. The minimal 
level of significance was P<0.05. Results are expressed as 
means "." S,E.M, 
3. RESULTS 
Fig. 1 displays the chromatographic profile of CNP- 
(51-103) and CNP-(I-103) found in the chromaffin cell 
acid extracts and eluting, respectively, at 34% and 47% 
of acetonitrile. In our chromatographic conditions, the 
immunoreactive signal corresponding to the shorter 
mature form, CNP-(82-103), and elating at 37% of ace- 
tonitrile, could not be detected in the bovine chromaffin 
cell extracts. Shown in Fig. 2 are the effects of l /zM 
FKL, 0.1 /,tM TPA and the combined treatment with 
both protein kinase A and -C activators over a 72-h 
period on the CNP levels within cultured chromaffin 
cells. In contrast o FKL or TPA alone, which do not 
appear to induce any significant change in the levels of 
both the mature and precursor forms of CNP, the com- 
bined treatment with both FKL and TPA elicits a syner- 
gistic effect on CNP-(I-103) levels (from 46 +_ 9 to 
298 + 66 from/4 × 107 (P < 0.001) which corresponds to 
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Fi~. 1. Reverse-phase HPLC separation profile of unstimu "luted (A)  
or stimulated (&) chromaffin cell extracts on the bidimensionai sys- 
tem. Peptides were elated with a 40 min linear sradient from 15 to 55% 
CH3CN in 25 mM triethylamine formate, pH 4.0, at a flow rate of 1 
ml/min. The HPLC eluates (1 ml) were evaporated todryness and the 
immunoreactive p ptides were determined by radioimmunoassay. 
CNP-(51-103), CNP-(82-103), and CNP-(I-103) elated at 34, 37 and 
47% of aeetonitrile, reslx~ctlvdy. Elution positions of standards CNP- 
(82-103) and CNP-(51-103) are indicated by arrows (1). The elution 
position of CNP.(I-103) is inferred from its relative retention time to 
that of CNP-(82-103) and CNP-(51-103) ( ) .  
a 6-fold stimulation. This stimulatory effect appears not 
to be as potent on the mature form of CNP (from 
140 __. 20 to 244 __. 51 fmol/4 x 107 cells). Fig. 3 illus- 
trates the co-secretion of both mature and precursor 
forms of CNP from chromaffin cells in which the CNP 
biosynthesis was first stimulated by pretreatments with 
both FKL and TPA for 72 h before subjecting the cells 
to 10/tM nicotinic stimulation or to 56 mM KCI as 
_J  
% zoo 
"l 
N 
} 
150 
O. 
I 
n.., 
CNP- (51-105)  CNP- (1 -103)  
 °jlj o°° 
I q -  8 8 8 9 7 8 7 8 
CTL FKL TPA T+F CTL FKL TPA T÷F 
Fig. 2. Biosynthesis of CNP-(51-103) and its precursor CNP-(I-103) 
by cultured chromaffin cells. Cells were seeded in 75 em' flasks and 
left to settle for 48 h after which they were stimulated by I ,uM 
lbrskolin (FKL), 0.1 ,aM phorbol ester (TPA) or the combined treat- 
ment (T + F) for 72 h. Cellular acid extracts were subjected to reverse- 
phase HPLC followed by RIA of CNP activity-containing fractions. 
Data are represented asmean ± S.E.M. (n = 8). Statistical significance 
was evalualed by ANOVA for CNP and its precursor levels followed 
by comparison to control (CTL) with Dunnett's test. ***P < 0.001. 
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Fi~. 3. Co.seeretion CNP-(51-103) and its precursor CNP-(I-103) by 
cultured ehromaffin cells. After 48 h ~ettling and 72 h stimulation with 
FKL (1 ,ttM) and TPA (0.1/aM), cells were exposed to 10,ttM nicotine 
(NIC) or 56 mM KCI (KCI). E×tr~teellular secretion media were sub. 
jeered to HPLC followed by RIA for CNP immunoreactivity detec- 
tion. Data are represented a5 mean _.+. S.E.M. Statistical significance 
was evaluated by ANOVA for CNP and its precursor levels followed 
by comparison to control (CTL) with Dunnett'5 test. *P < 0.05. 
depolarizing agent. When 10/.tM nicotine was added to 
the secretion medium, the basal evels or CNP-(51--103) 
and its precursor form, CNP.(I-103), which were 
14 _+ 5.2 finol and 20.8 __. 9 fmol/6 x 107 cells, respec- 
tive!y, increased up to 43.6 _.+ 9.4 fmol and 61 + 12.4 
fmol/6 × ]07 cells, corresponding to a 3-fold increase 
above the control evels. 
4. DISCUSSION 
The neuropeptide character of CNP, the third mem- 
ber of the natriuretic peptide family recently isolated 
from porcine brain, has been demonstrated b:¢ its bio- 
synthesis and secretion from cultured bovine chro- 
muffin cells. Indeed, the net 6-fold increase of the intra- 
cellular levels of the precursor form or CNP, CNP-(I- 
103), observed under the combined treatment with FKL 
and TPA0 is indicative of de novo synthesis of this pep- 
tide within the chrornaffin cells. However, no further 
maturation process of CNP-(I-103) was observed 
under this stimulatory condition since the proportion of 
the mature and precursor forms of CNP relative to each 
other appears to decrease. This contrasts with both 
ANF and ASIF whose intracellular ratio of mature vs. 
precursor forms remained unchanged in the presence of 
FKL and TPA [8]. The biosynthesis profile of the ma- 
ture tbrm of CNP is reminiscent of that of ANF with 
a 3--4 fold increase in intracellular levels promoted by 
protein kinase A and -C activators. As observed for 
other neuropeptides found in the chromaffin granules, 
e.g. enkephalin-containing peptides [10] and other 
natriuretic peptides [8], the concomitant exocytosis of 
both precursor and mature forms of CNP could be 
equipotently induced by nicotinic activation or KC1 de- 
polarization, corresponding to an average release or 
20% of their intracellular content. Interestingly, the 
ratio of CNP-(1-103) to its mature form CNP-(51-103) 
released in the incubation media, which averaged 1.4, 
was maintained upon the stimulation with both secre- 
~agogues and remained identical to the corresponding 
intracellular ratio, suggesting that no further processing 
seems to occur during exocytosis. Furthermore, the 
processing pattern of CNP in chromaffin cells is similar 
to that in the brain since CNP-(51-103) is the major 
mature form four, d in both tissues [2]. In contrast o 
other natriueretic peptides, it has been reported that 
CNP exhibits more potent vasoactive ffects [11]. 
Therefore, its potential role on the regulation of' the 
catecholamine secretion might be expected. Further 
work is needed to document the role of CNP in the 
modulation of' cateeholamines using the cultured chro- 
maffin cells as model. 
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